Patent details

Basic Information

Publication number:

EP1161234

PCT Application Number:

PCT/US/00/40040

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009202532

PCT Publication Number:

WO/00/05475

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF PULMONARY HYPERTENSION BY INHALATION OF BENZINDENE PROSTAGLANDINS

French Title of Invention:

TRAITEMENT DE L'HYPERTENSION PULMONAIRE PAR INHALATION DE BENZINDENE-PROSTAGLANDINES

German Title of Invention:

BEHANDLUNG DER PULMONALEN HYPERTENSION DURCH INHALATION VON BENZINDEN-PROSTAGLANDINE

SPC Number:

Dates

Filing date:

17/03/2000

Grant date:

30/07/2003

EP Publication Date:

30/07/2003

PCT Publication Date:

21/09/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/12/2001

EP B1 Publication Date:

30/07/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/03/2005

Expiration date:

17/03/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/03/2000

 

 

Name:

United Therapeutics Corporation

Address:

1826 R Street, N.W., Washington, DC 20009, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/10/2003

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CLOUTIER Gilles

Address:

United States (US)

2

Name:

CROW James

Address:

United States (US)

3

Name:

WADE Michael

Address:

United States (US)

4

Name:

PARKER Richard, E.

Address:

United States (US)

5

Name:

LOYD James, E.

Address:

United States (US)

Priority

Priority Number:

124999 P

Priority Date:

18/03/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/19;

Filing date	Document type	Number of pages